Lilly Says Its New Injectible Outperforms 3 Popular Diabetes Drugs

Good news for Eli Lilly & Co., as well as for type 2s who appreciate the addition of new drugs to treat their condition: Lilly says its once-weekly injectible drug, dulaglutide, has outperformed three other widely taken diabetes drugs in three just-concluded Phase III studies.

Summer Eating Tips for People With Diabetes

As we approach the summer season, our thoughts turn to barbecues, picnics, amusement parks, and road trips to the beach.

Metformin Could Protect Women Against Endometrial Cancer

British researchers say that metformin, the drug most often used to treat prediabetes and type 2 diabetes, could provide potential protection against endometrial cancer in women.